We help clinicians measure core ADHD symptoms: inattention, activity levels, and impulsivity.

These high-quality objective tests allow clinicians to get access to easy-to-interpret reports that compare individuals’ performance against an age and sex at birth matched control group. This data enables clinicians to:

- Reduce the time to diagnostic decision

- Better understand ADHD symptoms

- Improve communication with patients and their families. [1]

Qbtech offers both in-clinic and telehealth testing capabilities, which are conducted with a healthcare provider. Using a task administered on a computer, the in-clinic device uses an infrared tracking camera and head sensor to measure core ADHD symptoms – activity, inattention, and impulsivity – through a 15-20-minute computer-based test. Results are instantly analyzed and presented in a report that compares a patient's results with a group of people of the same age and gender at birth without ADHD.

About Qbtech

Founded in 2002, Qbtech is a privately-owned Swedish company. Our founders saw how time-consuming and opaque ADHD assessment could be when they started treatment and they began our mission to help improve the lives of people with ADHD. Out of that mission, we have developed leading solutions and products for improving the diagnosis, treatment and follow-up of patients living with ADHD.

Qbtech has operations in 13 countries and has offices in Stockholm, Houston, and London. Qbtech is an award-winning company recognized for their innovation, most recently winning the 2022 HSJ Partnership Award for the ‘Best Mental Health Partnership with the NHS’. www.qbtech.com

[1] Focus ADHD – AHSN Network. (n.d.). Retrieved December 7, 2022, from https://www.ahsnnetwork.com/about-academic-health-science-networks/national-programmes-priorities/adhd